|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF4E2-ACSL3 (FusionGDB2 ID:25967) |
Fusion Gene Summary for EIF4E2-ACSL3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF4E2-ACSL3 | Fusion gene ID: 25967 | Hgene | Tgene | Gene symbol | EIF4E2 | ACSL3 | Gene ID | 9470 | 2181 |
| Gene name | eukaryotic translation initiation factor 4E family member 2 | acyl-CoA synthetase long chain family member 3 | |
| Synonyms | 4E-LP|4EHP|EIF4EL3|IF4e|h4EHP | ACS3|FACL3|LACS 3|LACS3|PRO2194 | |
| Cytomap | 2q37.1 | 2q36.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | eukaryotic translation initiation factor 4E type 2eIF-4E type 2eIF4E-like cap-binding proteineIF4E-like protein 4E-LPeukaryotic translation initiation factor 4E homologous proteineukaryotic translation initiation factor 4E-like 3mRNA cap-binding pro | long-chain-fatty-acid--CoA ligase 3arachidonate--CoA ligasefatty-acid-Coenzyme A ligase, long-chain 3lignoceroyl-CoA synthaselong-chain acyl-CoA synthetase 3 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | O60573 | O95573 | |
| Ensembl transtripts involved in fusion gene | ENST00000258416, ENST00000409098, ENST00000409167, ENST00000409322, ENST00000409394, ENST00000409495, ENST00000409514, ENST00000479834, | ENST00000357430, ENST00000392066, | |
| Fusion gene scores | * DoF score | 7 X 7 X 5=245 | 7 X 6 X 5=210 |
| # samples | 7 | 7 | |
| ** MAII score | log2(7/245*10)=-1.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/210*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: EIF4E2 [Title/Abstract] AND ACSL3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EIF4E2(233431924)-ACSL3(223806215), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | EIF4E2-ACSL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. EIF4E2-ACSL3 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. EIF4E2-ACSL3 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. EIF4E2-ACSL3 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ACSL3 | GO:0044539 | long-chain fatty acid import | 20219900 |
| Fusion gene breakpoints across EIF4E2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across ACSL3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | TCGA-IN-8462-11A | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
Top |
Fusion Gene ORF analysis for EIF4E2-ACSL3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000258416 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409098 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409167 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409167 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409322 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409394 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409495 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| Frame-shift | ENST00000409514 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000258416 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000409098 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000409322 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000409394 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000409495 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| In-frame | ENST00000409514 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| intron-3CDS | ENST00000479834 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| intron-3CDS | ENST00000479834 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000409514 | EIF4E2 | chr2 | 233431924 | + | ENST00000392066 | ACSL3 | chr2 | 223806215 | + | 1433 | 707 | 42 | 725 | 227 |
| ENST00000409098 | EIF4E2 | chr2 | 233431924 | + | ENST00000392066 | ACSL3 | chr2 | 223806215 | + | 1433 | 707 | 42 | 725 | 227 |
| ENST00000409394 | EIF4E2 | chr2 | 233431924 | + | ENST00000392066 | ACSL3 | chr2 | 223806215 | + | 1277 | 551 | 21 | 569 | 182 |
| ENST00000258416 | EIF4E2 | chr2 | 233431924 | + | ENST00000392066 | ACSL3 | chr2 | 223806215 | + | 2064 | 1338 | 673 | 1356 | 227 |
| ENST00000409495 | EIF4E2 | chr2 | 233431924 | + | ENST00000357430 | ACSL3 | chr2 | 223806215 | + | 4020 | 877 | 36 | 611 | 191 |
| ENST00000409322 | EIF4E2 | chr2 | 233431924 | + | ENST00000392066 | ACSL3 | chr2 | 223806215 | + | 1289 | 563 | 33 | 581 | 182 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000409514 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.000877298 | 0.9991227 |
| ENST00000409098 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.000877298 | 0.9991227 |
| ENST00000409394 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.00255676 | 0.9974432 |
| ENST00000258416 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.002088686 | 0.9979113 |
| ENST00000409495 | ENST00000357430 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.000710008 | 0.99929 |
| ENST00000409322 | ENST00000392066 | EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806215 | + | 0.002451093 | 0.9975489 |
Top |
Fusion Genomic Features for EIF4E2-ACSL3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806214 | + | 4.18E-05 | 0.99995816 |
| EIF4E2 | chr2 | 233431924 | + | ACSL3 | chr2 | 223806214 | + | 4.18E-05 | 0.99995816 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for EIF4E2-ACSL3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:233431924/chr2:223806215) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EIF4E2 | ACSL3 |
| FUNCTION: Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation (PubMed:17368478, PubMed:25624349, PubMed:9582349). Acts as a repressor of translation initiation (PubMed:22751931). In contrast to EIF4E, it is unable to bind eIF4G (EIF4G1, EIF4G2 or EIF4G3), suggesting that it acts by competing with EIF4E and block assembly of eIF4F at the cap (By similarity). In P-bodies, component of a complex that promotes miRNA-mediated translational repression (PubMed:28487484). {ECO:0000250|UniProtKB:Q8BMB3, ECO:0000269|PubMed:17368478, ECO:0000269|PubMed:22751931, ECO:0000269|PubMed:25624349, ECO:0000269|PubMed:28487484, ECO:0000269|PubMed:9582349}. | FUNCTION: Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:22633490). Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins) (PubMed:18003621). Has mainly an anabolic role in energy metabolism. Mediates hepatic lipogenesis. Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates. Both isoforms exhibit the same level of activity (By similarity). {ECO:0000250|UniProtKB:Q63151, ECO:0000269|PubMed:18003621, ECO:0000269|PubMed:22633490}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 124_125 | 221 | 246.0 | Region | 7-methylguanosine-containing mRNA cap binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 150_157 | 221 | 246.0 | Region | EIF4EBP1/2/3 binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 174_179 | 221 | 246.0 | Region | 7-methylguanosine-containing mRNA cap binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 222_224 | 221 | 246.0 | Region | 7-methylguanosine-containing mRNA cap binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 54_57 | 221 | 246.0 | Region | EIF4EBP1/2/3 binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 78_79 | 221 | 246.0 | Region | 7-methylguanosine-containing mRNA cap binding |
| Hgene | EIF4E2 | chr2:233431924 | chr2:223806215 | ENST00000258416 | + | 6 | 7 | 95_99 | 221 | 246.0 | Region | EIF4EBP1/2/3 binding |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | ACSL3 | chr2:233431924 | chr2:223806215 | ENST00000357430 | 15 | 17 | 42_720 | 668 | 721.0 | Topological domain | Cytoplasmic | |
| Tgene | ACSL3 | chr2:233431924 | chr2:223806215 | ENST00000392066 | 14 | 16 | 42_720 | 668 | 721.0 | Topological domain | Cytoplasmic | |
| Tgene | ACSL3 | chr2:233431924 | chr2:223806215 | ENST00000357430 | 15 | 17 | 21_41 | 668 | 721.0 | Transmembrane | Helical%3B Signal-anchor for type III membrane protein | |
| Tgene | ACSL3 | chr2:233431924 | chr2:223806215 | ENST00000392066 | 14 | 16 | 21_41 | 668 | 721.0 | Transmembrane | Helical%3B Signal-anchor for type III membrane protein |
Top |
Fusion Gene Sequence for EIF4E2-ACSL3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >25967_25967_1_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000258416_ACSL3_chr2_223806215_ENST00000392066_length(transcript)=2064nt_BP=1338nt TGACAATAGCAACATCAAAGATCACTGATCATAGATCACCATAACAGACACAGAAATCATGAAAAAGTTTTAAATATTTTGAGAATTACC AAAATGTAACACAGAGACACCAAGTGAGCACATGCTGTTGGAAAAATGGCGCTGATACAATTGCTGGACTCAGGGCTGCCACAAACCCTC CATTTGTTTTCAGAATGCCCTATCTGCGAAGCGTAATAAAACGAGGTATGCCATAGTACAGTGGCGCCGCGACCGACAAAGGAAAGCCTC CGGGAGGTCAAAAGAGATACCAGAGAGTGCGTCCCGCACTGGAGGAAGAGGAAGGTTTTTACCAAGCAGCGAGTCCAGAGCCCGCGCCGT CAACGACGCGGTGCTGCCTTTTTTCCGAGCCGCTGCGGGAGGGGGCCAGGACACGCTCCCTTAGGAGAGCGGGCGGGTCACAAGGACCTG GACAGAGGCAGAACTGAGGCCAGCAGCCAGCTCCGCCGCTGAGTCCAGCCCTCTGCGCAGCCGCCCTGAGCTGGCGTCCCGAGATAGCCG CTTCCAAACCGGGCCTGCGCGCCGACGTTCCGCTGCGCCCCGCGCAAAACCGGAAGTACCCGGGCCCAAGGCTGAGGGACCCGGTGGAGC GGAAGTCACTCCCTGAGGCAGTGGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCA TGATCAGAATGAAGAAAACAGCACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGC TGTTGTCCCTGGACCGGCAGAGCATCCCCTGCAGTACAACTACACTTTTTGGTACTCCAGGAGAACCCCCGGCCGTCCCACGAGCTCACA GAGCTATGAACAGAATATCAAACAGATTGGCACCTTTGCCTCTGTGGAGCAGTTCTGGAGGTTTTATAGCCACATGGTACGTCCTGGGGA CCTGACAGGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGGGAGGATGATGCAAATAAAAATGGTGGCAAGTGGAT TATTCGGCTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCCATGCTGGGGGAACAGTTCATGGTTGGGGAGGAGAT CTGTGGGGCTGTGGTGTCTGTCCGCTTTCAGGAAGACATTATTTCAATATGGAATAAGACTGCCAGTGACCAAGCAACCACAGCCCGAAT CCGGGACACACTTCGGCGAGTGCTTAACCTACCTCCCAACACCATTATGGAATACAAAACTCACACCGACAGCATCAACAAGTCTGGAAA AGTTTGAAATTCCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAACTGGTCTGGTGACAGATGCCTTCAAGCTGAAACGCA AAGAGCTTAAAACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATAATTATTCTCTTCTGGCATCAGTTTGCTACAGTGAG CTCAGATCAAATAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACTCCATTCCTCATATTAAACTATTACTTCTCATGACG TCACCATTTTTAACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCTGTCTCTTCTTTCATTTTCCCCGCCACCAACTTACT TTACCACCTATGACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGGAAGCAGTGATTTTAAAACCTCAAGTTTTTAAACAT GATTTATATGTTCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTATAGAGGGATAAATAGGAAATATAAGAATTGGTTAT TTGGGGGCTTTTTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATTATGTAAATTTCAAATGCTTATGAATCAAATCATTG >25967_25967_1_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000258416_ACSL3_chr2_223806215_ENST00000392066_length(amino acids)=227AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKAVVPGPAEHPLQYNYTFWYSRRTPGRPTSSQSYEQNIKQIGTFAS VEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKWIIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQEDII -------------------------------------------------------------- >25967_25967_2_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409098_ACSL3_chr2_223806215_ENST00000392066_length(transcript)=1433nt_BP=707nt GAAGTCACTCCCTGAGGCAGTGGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCAT GATCAGAATGAAGAAAACAGCACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGCT GTTGTCCCTGGACCGGCAGAGCATCCCCTGCAGTACAACTACACTTTTTGGTACTCCAGGAGAACCCCCGGCCGTCCCACGAGCTCACAG AGCTATGAACAGAATATCAAACAGATTGGCACCTTTGCCTCTGTGGAGCAGTTCTGGAGGTTTTATAGCCACATGGTACGTCCTGGGGAC CTGACAGGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGGGAGGATGATGCAAATAAAAATGGTGGCAAGTGGATT ATTCGGCTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCCATGCTGGGGGAACAGTTCATGGTTGGGGAGGAGATC TGTGGGGCTGTGGTGTCTGTCCGCTTTCAGGAAGACATTATTTCAATATGGAATAAGACTGCCAGTGACCAAGCAACCACAGCCCGAATC CGGGACACACTTCGGCGAGTGCTTAACCTACCTCCCAACACCATTATGGAATACAAAACTCACACCGACAGCATCAACAAGTCTGGAAAA GTTTGAAATTCCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAACTGGTCTGGTGACAGATGCCTTCAAGCTGAAACGCAA AGAGCTTAAAACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATAATTATTCTCTTCTGGCATCAGTTTGCTACAGTGAGC TCAGATCAAATAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACTCCATTCCTCATATTAAACTATTACTTCTCATGACGT CACCATTTTTAACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCTGTCTCTTCTTTCATTTTCCCCGCCACCAACTTACTT TACCACCTATGACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGGAAGCAGTGATTTTAAAACCTCAAGTTTTTAAACATG ATTTATATGTTCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTATAGAGGGATAAATAGGAAATATAAGAATTGGTTATT TGGGGGCTTTTTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATTATGTAAATTTCAAATGCTTATGAATCAAATCATTGT >25967_25967_2_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409098_ACSL3_chr2_223806215_ENST00000392066_length(amino acids)=227AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKAVVPGPAEHPLQYNYTFWYSRRTPGRPTSSQSYEQNIKQIGTFAS VEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKWIIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQEDII -------------------------------------------------------------- >25967_25967_3_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409322_ACSL3_chr2_223806215_ENST00000392066_length(transcript)=1289nt_BP=563nt CCCTGAGGCAGTGGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCATGATCAGAAT GAAGAAAACAGCACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGTGGAGCAGTTC TGGAGGTTTTATAGCCACATGGTACGTCCTGGGGACCTGACAGGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGG GAGGATGATGCAAATAAAAATGGTGGCAAGTGGATTATTCGGCTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCC ATGCTGGGGGAACAGTTCATGGTTGGGGAGGAGATCTGTGGGGCTGTGGTGTCTGTCCGCTTTCAGGAAGACATTATTTCAATATGGAAT AAGACTGCCAGTGACCAAGCAACCACAGCCCGAATCCGGGACACACTTCGGCGAGTGCTTAACCTACCTCCCAACACCATTATGGAATAC AAAACTCACACCGACAGCATCAACAAGTCTGGAAAAGTTTGAAATTCCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAAC TGGTCTGGTGACAGATGCCTTCAAGCTGAAACGCAAAGAGCTTAAAACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATA ATTATTCTCTTCTGGCATCAGTTTGCTACAGTGAGCTCAGATCAAATAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACT CCATTCCTCATATTAAACTATTACTTCTCATGACGTCACCATTTTTAACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCT GTCTCTTCTTTCATTTTCCCCGCCACCAACTTACTTTACCACCTATGACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGG AAGCAGTGATTTTAAAACCTCAAGTTTTTAAACATGATTTATATGTTCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTA TAGAGGGATAAATAGGAAATATAAGAATTGGTTATTTGGGGGCTTTTTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATT ATGTAAATTTCAAATGCTTATGAATCAAATCATTGTTGAACAAAAGATTTGTTGCTGTGTAATTATTGTCTTGTATGCATTTGAGAGAAA >25967_25967_3_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409322_ACSL3_chr2_223806215_ENST00000392066_length(amino acids)=182AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKVEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKW IIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQEDIISIWNKTASDQATTARIRDTLRRVLNLPPNTIMEYKTHTDSINKSG -------------------------------------------------------------- >25967_25967_4_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409394_ACSL3_chr2_223806215_ENST00000392066_length(transcript)=1277nt_BP=551nt GGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCATGATCAGAATGAAGAAAACAGC ACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGTGGAGCAGTTCTGGAGGTTTTAT AGCCACATGGTACGTCCTGGGGACCTGACAGGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGGGAGGATGATGCA AATAAAAATGGTGGCAAGTGGATTATTCGGCTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCCATGCTGGGGGAA CAGTTCATGGTTGGGGAGGAGATCTGTGGGGCTGTGGTGTCTGTCCGCTTTCAGGAAGACATTATTTCAATATGGAATAAGACTGCCAGT GACCAAGCAACCACAGCCCGAATCCGGGACACACTTCGGCGAGTGCTTAACCTACCTCCCAACACCATTATGGAATACAAAACTCACACC GACAGCATCAACAAGTCTGGAAAAGTTTGAAATTCCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAACTGGTCTGGTGAC AGATGCCTTCAAGCTGAAACGCAAAGAGCTTAAAACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATAATTATTCTCTTC TGGCATCAGTTTGCTACAGTGAGCTCAGATCAAATAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACTCCATTCCTCATA TTAAACTATTACTTCTCATGACGTCACCATTTTTAACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCTGTCTCTTCTTTC ATTTTCCCCGCCACCAACTTACTTTACCACCTATGACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGGAAGCAGTGATTT TAAAACCTCAAGTTTTTAAACATGATTTATATGTTCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTATAGAGGGATAAA TAGGAAATATAAGAATTGGTTATTTGGGGGCTTTTTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATTATGTAAATTTCA AATGCTTATGAATCAAATCATTGTTGAACAAAAGATTTGTTGCTGTGTAATTATTGTCTTGTATGCATTTGAGAGAAATAAATATACCCA >25967_25967_4_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409394_ACSL3_chr2_223806215_ENST00000392066_length(amino acids)=182AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKVEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKW IIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQEDIISIWNKTASDQATTARIRDTLRRVLNLPPNTIMEYKTHTDSINKSG -------------------------------------------------------------- >25967_25967_5_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409495_ACSL3_chr2_223806215_ENST00000357430_length(transcript)=4020nt_BP=877nt ACTCCCTGAGGCAGTGGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCATGATCAG AATGAAGAAAACAGCACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGCTGTTGTC CCTGGACCGGCAGAGCATCCCCTGCAGTACAACTACACTTTTTGGTACTCCAGGAGAACCCCCGGCCGTCCCACGAGCTCACAGAGCTAT GAACAGAATATCAAACAGATTGGCACCTTTGCCTCTGTGGAGCAGTTCTGGAGGTTTTATAGCCACATGGTACGTCCTGGGGACCTGACA GGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGGGAGGATGATGCAAATAAAAATGGTGGCAAGTGGATTATTCGG CTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCCATGCTGGGGGAACAGTTCATGGTTGGGGAGGAGATCTGTGGG GCTGTGGTGTCTGTCCGCTTTCAGGTACGTGTTGGGGGGTTATGGGAGGACGTGTCCCTAAGCTTAGTATAAGTAGATCTGTAGTTGGGC CCAGAGGAATATGGCCGGACAGGAGACTTACTTGTGGAGAAGGGACAGACCAGGCCTTCCCTCTAGGGCTTCTGGCTACTTGCTGCAGTT CTTTGTCAGCGAGGCTCCCTGCCACCTATACTACCAGGTGCTTTGTAGCAGAGAGAGCCCATCTGCAGAAACCCAGTTGTACTACCTGGG CTTGCTTAATTTCTACAGGCTGTCTTGTCTTTCATATGCTAACCACTATCTTAAAATGAAAGACAAGCAAGTCTGGAAAAGTTTGAAATT CCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAACTGGTCTGGTGACAGATGCCTTCAAGCTGAAACGCAAAGAGCTTAAA ACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATAATTATTCTCTTCTGGCATCAGTTTGCTACAGTGAGCTCAGATCAAA TAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACTCCATTCCTCATATTAAACTATTACTTCTCATGACGTCACCATTTTT AACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCTGTCTCTTCTTTCATTTTCCCCGCCACCAACTTACTTTACCACCTAT GACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGGAAGCAGTGATTTTAAAACCTCAAGTTTTTAAACATGATTTATATGT TCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTATAGAGGGATAAATAGGAAATATAAGAATTGGTTATTTGGGGGCTTT TTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATTATGTAAATTTCAAATGCTTATGAATCAAATCATTGTTGAACAAAAG ATTTGTTGCTGTGTAATTATTGTCTTGTATGCATTTGAGAGAAATAAATATACCCATACTTATGTTTTAAGAAGTTGAGATCTTGTGAAT ATATGCCTGTCAGTGTCTTCTTTATATATTTATTTTTTATTAGAAAAAATGAAGTTTGGTTGGTGATGCATGAAACAAAATAGCAAGAGA GGGTTATAGTTTAATAGTAAGGGAGATAACACAGCATGTGTAGCACCAGTTGATAATTGGTCTCTAGTAGCTTACTGTCAAAATGTTCAA TGAAGTCTTCTGTTCATCTGTTGAAACTAGGAAAATACCCAAACTTAAATGGAAGAATTCTGAAAGAGAGGATAGAATTTAAAGAACAAG AGTATATAAAGTTATTCTTTGAATATTTCGTTGACTATATGTACATTGAGTTATCTATATTTGTAAACAAATTAGTCATGGAAAATTATT CTATCTCAAAGTCTCCTTTTAGTCTAGATAATCATTATTTCATTTTAAAATTAGTGTTTTTCCTAGTTTGCACTGATGCGTGTATGGATG TGTGTGAGTCAGTGGTAGCTTATTTAAAAAGCACCTTATCCTTTCTCCCATAACCTTTGTACACTAAAAAATGAAAGAATTTAGAATGTA TTTGATGATAGCATTCTCACTAAGACACATGAGAATTTAACTTTATAACCGCGTGAGTTAAGATTTAATTCATAGGTTTTGATGTCATTG TTGAAGTTATTTGTAATTCAGAAACCTTGCTTGTGTGATACATAGTCTCTTCATTTATTACTGCTTGTCTGTTGTTATATCTGGATTATC AAAAGCAATAGTGCACCAATTAAGATGTGCTCAAATCAGGACTTAAATCATAGGCACCACATTTTTCATGTCAGACTAGTTACTTTGTTG ATTCTCAGTTACTGTAGGCATCAAAAGGCAAAAATCAAAAAAAAAAAAAACAAAAACAAAAAAAAAGATGAACCTAGGTCTGTGTAAAGT AAGGGGAGTGTTAGGAGCAGCCAGGACTGTGTAGTGTGTGTTTGGTTGCATCACAAACATCGTATGTGGAGACATTGCAATACAGTGTTT TTTGTTTTCAACTTTTCTTGTATTGTATATTTGTATTATGTTTTGAATGCTTTTCTCTTTTCATAATTAAATATTAATGTTTGGGATAAC TGCCAAGAAGAAGTAAAAATATTGAATGGAACTTCTATATGAGGATGCTGTGATCTAAAAATTAAATCTCAGTGGGCGGAGAGAATTTGT TTCTGATGCCTTGTCTTTAGAATAATTGTTTGCTTTCAGATGATTAAAAAAAGGAGATTGTATCTAGGAAAAAAGTGTGAATGCTTCAAA GGAGAGATACTGATAATTGTGACTTGAAATAGTGTCAGATGAATTATGTAGCTGATCACTGATGGAACCATCTAATGAGGCAGGCTTAAA CTCTATTTAGTTTCGTTTGTTTTCTCATATGAAGTTTATAATTCCTTTCAGTCCTAAAATGTCAGATGCCAGGTGTCAAATGCCACAGTA GAAAGTGAAATTAAGTAGAGTCCCCTTTTAAACAAATTTGTCTGTAAGCAAAACTATCTTTAGTGACTTAAAAAATAATATCCTCTAAAA TTACCCTTTCAAGAGGAAAAAACTGTTCAATGAAAAAACCACTCAATTATGACTCATATAAGAAATACTGGTTTAACCAGGAGATATTTG GGGAGCAAAATTTTAAGGAATTTCAAATTGCTAAATCTAATACAAATATCTGACAATAAGATACAGATCTAAAAGAATGGTTCTTAAGAA CTATTGTTTACTGGGAATAAACTAAGCTCTATGAAGAATTCGTAAGCATTACATGTTCCAGTAAGTTTAGCAACTTAGAGCCAAGACTGG TGGCCACCTCCATTTATTTCCCCACTGCTCCTCCACTGACATCCTTCTTAGCAGAAACTTCATGAAAAAGTTTTTGCTGACACAGAACAA ACCTGAAAGTAGTATCTACTTTCTAAATACTACTTTGCTTTTCAGTAGTGGATTTGATATTTATAATGTTCTCTAAAGCTTGCAACTTTT TCAGCAACGTTTAAAAATAGATTAACCTGGAATAACTTACTTGTTTGCTGCTAAAATACTCAAGATTTTGCCATTTTTAAACAACCAGTC CCTGTGATACAACTTTGAAAAAACTTTTAAAAATCTCTGATGTGTGGGCTCTTTTTTTCCCATAAGAATTATGTACATCTGTGATGTTTT ACAGGGGGATCCGCTTTTAAACAGTGTACATATTGGACCACACTGAAATGTCATATATCCTTTCTCTACTTAAAATTGGTTATTTACTGT GAGTTCATTTCCGATGTGTTCTTGGTTGTTGCTGTTTTCTGCCTGAAGACGTGTATCATAAAGAGCTACATGGTATGGACTATTTATTTG >25967_25967_5_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409495_ACSL3_chr2_223806215_ENST00000357430_length(amino acids)=191AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKAVVPGPAEHPLQYNYTFWYSRRTPGRPTSSQSYEQNIKQIGTFAS VEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKWIIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQVRVG -------------------------------------------------------------- >25967_25967_6_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409514_ACSL3_chr2_223806215_ENST00000392066_length(transcript)=1433nt_BP=707nt GAAGTCACTCCCTGAGGCAGTGGCGACAGCGGCGGCGAGAGGATGAACAACAAGTTCGACGCTTTGAAAGATGATGACAGTGGGGACCAT GATCAGAATGAAGAAAACAGCACACAGAAAGATGGTGAGAAGGAAAAAACGGAACGAGACAAGAATCAGAGCAGTAGCAAGAGAAAGGCT GTTGTCCCTGGACCGGCAGAGCATCCCCTGCAGTACAACTACACTTTTTGGTACTCCAGGAGAACCCCCGGCCGTCCCACGAGCTCACAG AGCTATGAACAGAATATCAAACAGATTGGCACCTTTGCCTCTGTGGAGCAGTTCTGGAGGTTTTATAGCCACATGGTACGTCCTGGGGAC CTGACAGGCCACAGTGACTTCCATCTCTTCAAAGAAGGAATTAAACCCATGTGGGAGGATGATGCAAATAAAAATGGTGGCAAGTGGATT ATTCGGCTGCGGAAGGGCTTGGCCTCCCGTTGCTGGGAGAATCTCATTTTGGCCATGCTGGGGGAACAGTTCATGGTTGGGGAGGAGATC TGTGGGGCTGTGGTGTCTGTCCGCTTTCAGGAAGACATTATTTCAATATGGAATAAGACTGCCAGTGACCAAGCAACCACAGCCCGAATC CGGGACACACTTCGGCGAGTGCTTAACCTACCTCCCAACACCATTATGGAATACAAAACTCACACCGACAGCATCAACAAGTCTGGAAAA GTTTGAAATTCCAGTAAAAATTCGTTTGAGTCCTGAACCGTGGACCCCTGAAACTGGTCTGGTGACAGATGCCTTCAAGCTGAAACGCAA AGAGCTTAAAACACATTACCAGGCGGACATTGAGCGAATGTATGGAAGAAAATAATTATTCTCTTCTGGCATCAGTTTGCTACAGTGAGC TCAGATCAAATAGGAAAATACTTGAAATGCATGTCTCAAGCTGCAAGGCAAACTCCATTCCTCATATTAAACTATTACTTCTCATGACGT CACCATTTTTAACTGACAGGATTAGTAAAACATTAAGACAGCAAACTTGTGTCTGTCTCTTCTTTCATTTTCCCCGCCACCAACTTACTT TACCACCTATGACTGTACTTGTCAGTATGAGAATTTTTCTGAATCATATTGGGGAAGCAGTGATTTTAAAACCTCAAGTTTTTAAACATG ATTTATATGTTCTGTATAATGTTCAGTTTGTAACTTTTTAAAAGTTTGGATGTATAGAGGGATAAATAGGAAATATAAGAATTGGTTATT TGGGGGCTTTTTTACTTACTGTATTTAAAAATACAAGGGTATTGATATGAAATTATGTAAATTTCAAATGCTTATGAATCAAATCATTGT >25967_25967_6_EIF4E2-ACSL3_EIF4E2_chr2_233431924_ENST00000409514_ACSL3_chr2_223806215_ENST00000392066_length(amino acids)=227AA_BP= MNNKFDALKDDDSGDHDQNEENSTQKDGEKEKTERDKNQSSSKRKAVVPGPAEHPLQYNYTFWYSRRTPGRPTSSQSYEQNIKQIGTFAS VEQFWRFYSHMVRPGDLTGHSDFHLFKEGIKPMWEDDANKNGGKWIIRLRKGLASRCWENLILAMLGEQFMVGEEICGAVVSVRFQEDII -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EIF4E2-ACSL3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF4E2-ACSL3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF4E2-ACSL3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies